SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 547.50 |
| Enterprise Value ($M) | -173.05 |
| Book Value ($M) | 728.87 |
| Book Value / Share | 17.95 |
| Price / Book | 0.75 |
| NCAV ($M) | 703.82 |
| NCAV / Share | 17.33 |
| Price / NCAV | 0.78 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.01 |
| Return on Assets (ROA) | 0.01 |
| Return on Equity (ROE) | 0.01 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 19.29 |
| Current Ratio | 19.29 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 759.51 |
| Assets | 784.56 |
| Liabilities | 55.69 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 3.55 |
| Operating Income | -210.83 |
| Net Income | -187.35 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -160.87 |
| Cash from Investing | -1.93 |
| Cash from Financing | 391.82 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | ADAR1 Capital Management, LLC | 13.27 | 0.00 | |
| 13G/A | Jpmorgan Chase & Co | 0.20 | -95.60 | |
| 13G | Vanguard Group Inc | 6.32 | ||
| 13D/A | Pontifax Management 4 G.p. (2015) Ltd. | 11.80 | 1.12 | |
| 13G | Alkeon Capital Management Llc | 2.70 | -26.55 | |
| 13G/A | Fmr Llc | 1.70 | -81.82 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 87,828 | 431,878 | 20.34 | |
| 178,284 | 1,119,646 | 15.92 | |
| 86,086 | 449,886 | 19.14 | |
| 135,932 | 700,247 | 19.41 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| KALV – KalVista Pharmaceuticals, Inc. | KLTO – Klotho Neurosciences, Inc. |
| KOD – Kodiak Sciences Inc. | KYMR – Kymera Therapeutics, Inc. |
| LGND – Ligand Pharmaceuticals Incorporated |
Financial data and stock pages provided by
Fintel.io